1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 17 AUGUST 2015

Cancer Drug News 17 AUGUST 2015

  • August 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Checkpoint Inhibitors Will Assert Dominance Over New Wave Of Immuno-Oncology
Industry Brief - Onconova Submits IND For Phase III Trial Of IV Rigosertib In HR-MDS
Industry Brief - FDA Approves Sprycel Label Update
Industry Brief - Alvogen Launches Bortezomib In Bulgaria
Industry Trend Analysis - Venetoclax Will Bolster AbbVie's Strategically Important Haematological Cancer Franchise
Industry Brief - Immune Design/Merck Enter Immuno-Oncology Clinical Trial Collaboration
Industry Brief - Poseida Licenses Janssen's Centyrin Technology To Develop CAR Therapies
Industry Brief - Genentech's Atezolizumab Phase II LC Study Meets Primary Endpoint
Industry Brief - Threshold Begins First Tarloxotinib Phase II Trial In EGFr-Mutant T790M-Negative NSCLC
Industry Brief - Clovis/Genentech Enter Clinical Trial Collaboration In Advanced NSCLC
Industry Brief - Hikma Challenges Abiraterone Patent
Industry Brief - Unituxin Gains EU Approval For Paediatric High-Risk Neuroblastoma
Industry Brief - ImmunoCellular/FDA Reach SPA Agreement On ICT-107 Phase III Glioblastoma Trial
Industry Brief - FDA Extends Action Date For Opdivo sBLA In Advanced Melanoma
Industry Trend Analysis - Mallinckrodt To Expand Hospital Growth Platform With Therakos Acquisition
Industry Trend Analysis - Importance Of Industry/Academia Partnership Increasing
Industry Brief - Genmab Licenses DuoBody Platform To Novo Nordisk
Industry Brief - Janssen Licenses TNF Receptor Superfamily Targeted Agent From Alligator
Industry Brief - Checkmate Secures Funding For Development Of Immuno-Oncology Products
Industry Trend Analysis - Pfizer/Hospira Growth Prospects Undiminished Despite EC Biosimilar Ruling

Table Of Contents

Cancer Drug News 17 AUGUST 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung ...

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 6400
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,800.  DataPack (test volumes, sales forecasts, supplier shares) $6,400. Highlights Comprehensive 620-page analysis of the US tumor marker testing market.Major issues pertaining to the ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.